Filing Details

Accession Number:
0001181431-13-019221
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-27 20:10:51
Reporting Period:
2013-03-25
Filing Date:
2013-03-27
Accepted Time:
2013-03-27 20:10:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1373707 Tetraphase Pharmaceuticals Inc TTPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277503 Yasunori Kaneko 525 University Ave., Ste 610
Palo Alto CA 94301
No No Yes No
1324617 P L Iv Fund Purchaser Qualified Partners Venture Skyline 525 University Ave., Ste 610
Palo Alto CA 94301
No No Yes No
1392103 Skyline Venture Management Iv, Llc 525 University Ave., Ste 610
Palo Alto CA 94301
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-25 72,069 $0.00 82,414 No 4 C Direct
Common Stock Acquisiton 2013-03-25 94,003 $0.00 176,417 No 4 C Direct
Common Stock Acquisiton 2013-03-25 393,863 $0.00 570,280 No 4 C Direct
Common Stock Acquisiton 2013-03-25 938,853 $0.00 1,509,133 No 4 C Direct
Common Stock Acquisiton 2013-03-25 681,012 $7.00 2,190,145 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-1 Convertible Participating Preferred Stock Disposition 2013-03-25 2,090,000 $0.00 72,069 $0.00
Common Stock Series A-2 Convertible Participating Preferred Stock Disposition 2013-03-25 2,726,086 $0.00 94,003 $0.00
Common Stock Series B Convertible Participating Preferred Stock Disposition 2013-03-25 11,422,045 $0.00 393,863 $0.00
Common Stock Series C Convertible Participating Preferred Stock Disposition 2013-03-25 27,226,760 $0.00 938,853 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. The Series A-1, Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the issuer's initial public offering without payment of consideration.
  2. Skyline Venture Management IV, LLC is the General Partner of Skyline Venture Partners Qualified Purchaser IV L.P. Yasunori Kaneko is the Managing Director of Skyline Venture Management IV, LLC. Skyline Venture Management IV, LLC and this individual may be deemed to share voting and dispositive power with respect to all shares held by Skyline Venture Partners Qualified Purchaser IV L.P. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
  3. Not Applicable